Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease

被引：8

作者：

Elchynski, Amanda L. ^{[1
,2
]}

Cicali, Emily J. ^{[1
,2
]}

Ferrer del Busto, Maria C. ^{[1
]}

Hamilton, Alessandra ^{[1
]}

Chang, Ku-Lang ^{[3
]}

Schmidt, Siegfried O. ^{[3
]}

Weiner, Brian ^{[4
,7
,8
]}

Davis, Richard ^{[4
]}

Estores, David ^{[4
]}

Max Smith, D. ^{[5
,6
]}

Wiisanen, Kristin ^{[1
,2
]}

Johnson, Julie A. ^{[1
,2
]}

Cavallari, Larisa H. ^{[1
,2
]}

机构：

[1] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 02115 USA

[2] Univ Florida, Coll Pharm, Ctr Pharmacogen & Precis Med, Gainesville, FL 02115 USA

[3] Univ Florida, Coll Med, Dept Community Hlth & Family Med, Gainesville, FL USA

[4] Univ Florida, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA

[5] MedStar Hlth, Columbia, MD USA

[6] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC USA

[7] Florida Atlantic Univ, Charles E Schmidt Sch Med, Boca Raton, FL USA

[8] Cleveland Clin, Digest Dis Inst, Weston, FL USA

来源：

PHARMACOGENOMICS JOURNAL | 2021年 / 21卷 / 06期

关键词：

PREVALENCE;

D O I：

10.1038/s41397-021-00244-6

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

We aimed to determine the potential value of panel-based pharmacogenetic (PGx) testing in patients with chronic pain or gastroesophageal reflux disease (GERD) who underwent single-gene PGx testing to guide opioid or proton pump inhibitor (PPI) therapy, respectively. Of 448 patients included (chronic pain, n = 337; GERD, n = 111), mean age was 57 years, 68% were female, and 73% were white. Excluding opiates for the pain cohort and PPIs for the GERD cohort, 76.6% of patients with pain and 71.2% with GERD were prescribed at least one additional medication with a high level of PGx evidence, most commonly ondansetron or selective serotonin reuptake inhibitors. The most common genes that could inform PGx drug prescribing were CYP2C19, CYP2D6, CYP2C9, and SLCO1B1. Our findings suggest that patients with chronic pain or GERD are commonly prescribed drugs with a high level of evidence for a PGx-guided approach, supporting panel-based testing in these populations.

引用

页码：657 / 663

页数：7

共 43 条

[31] The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications
Bautista, JM
Wong, WM
Pulliam, G
Esquivel, RF
Fass, R
[J]. DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) : 1909 - 1915
[32] The Value of Ambulatory 24 hr Esophageal pH Monitoring in Clinical Practice in Patients Who Were Referred with Persistent Gastroesophageal Reflux Disease (GERD)-Related Symptoms While on Standard Dose Anti-Reflux Medications
Jimmy M. Bautista
Wai-man Wong
Gloria Pulliam
Romeo F. Esquivel
Ronnie Fass
[J]. Digestive Diseases and Sciences, 2005, 50 : 1909 - 1915
[33] Identification of numerous novel disease-causing variants in patients with inherited retinal diseases, combining careful clinical-functional phenotyping with systematic, broad NGS panel-based genotyping
Gupta, Priya R.
Kheir, Wajiha
Peng, Bo
Duan, Jie
Iannaccone, Alessandro
[J]. MOLECULAR VISION, 2022, 28 : 202 - 217
[34] Identification of numerous novel disease-causing variants in patients with inherited retinal diseases, combining careful clinical-functional phenotyping with systematic, broad NGS panel-based genotyping
Gupta, Priya R.
Kheir, Wajiha
Peng, Bo
Duan, Jie
Chiang, John P-W.
Iannaccone, Alessandro
[J]. MOLECULAR VISION, 2022, 28 : 203 - 219
[35] Bilateral Sensory Changes and High Burden of Disease in Patients With Chronic Pain and Unilateral Nondermatomal Somatosensory Deficits: A Quantitative Sensory Testing and Clinical Study
Landmann, Gunther
Dumat, Wolfgang
Egloff, Niklaus
Gantenbein, Andreas R.
Matter, Sibylle
Pirotta, Roberto
Sandor, Peter S.
Schleinzer, Wolfgang
Seifert, Burkhardt
Sprott, Haiko
Stockinger, Lenka
Riederer, Franz
[J]. CLINICAL JOURNAL OF PAIN, 2017, 33 (08): : 746 - 755
[36] Careful clinical-functional phenotyping combined with systematic, broad NGS Panel-based genotyping identify numerous novel disease-causing mutations and deletions in inherited retinal dystrophy (IRD) patients
Iannaccone, Alessandro
Berdia, Jay
Kheir, Wajiha
Mighion, Lindsay
Wang, Nicholas
DaSilva, Cristina
Duan, Jie
Alexander, John J.
Chiang, John
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[37] IDENTIFICATION OF NEUROPATHIC PAIN USING CLINICAL SURROGATES BASED ON PANCREATIC QUANTITATIVE SENSORY TESTING (P-QST) IN PATIENTS WITH CHRONIC PANCREATITIS.
Unnisa, Misbah
Chinthakuntla, Madhurya Reddy
Goud, Maragoni R.
Javvaji, Sai Sowmya
Sarkar, Subhaleena
Patel, Archi
Mehta, Rajiv
Jagtap, Nitin
Drewes, Asbjorn M.
Olesen, Soren S.
Duvvur, Nageshwar R.
Talukdar, Rupjyoti
[J]. GASTROENTEROLOGY, 2023, 164 (06) : S117 - S117
[38] Clinical Benefit of Performing 24-Hour pH-Impedance Testing in Addition to 48-Hour pH Capsule Studies During Evaluation of Patients With Suspected Refractory Gastroesophageal Reflux Disease (GERD)
Khan, Ella
Malik, Zubair
Fisher, Robert
Parkman, Henry
Smith, Michael
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S27 - S27
[39] RECEIPT AND YIELD OF DIAGNOSTIC TESTING FOR PATIENTS PRESCRIBED TWICE-DAILY, LONG-TERM PROTON PUMP INHIBITOR (PPI) FOR GASTROESOPHAGEAL REFLUX DISEASE VARY BASED ON GASTROENTEROLOGY EVALUATION AND PPI PRESCRIBER SPECIALTY
Hein, Aaron
Helzberg, James H.
Osborne, Kelly M.
Kothari, Darshan
Leiman, David A.
Patel, Amit
[J]. GASTROENTEROLOGY, 2023, 164 (06) : S581 - S582
[40] The Added Value of Face-to-Face Supervision to a Therapeutic Exercise-Based App in the Management of Patients with Chronic Low Back Pain: A Randomized Clinical Trial
Lopez-Marcos, Jose Javier
Diaz-Arribas, Maria Jose
Valera-Calero, Juan Antonio
Navarro-Santana, Marcos Jose
Izquierdo-Garcia, Juan
Ortiz-Gutierrez, Rosa Maria
Plaza-Manzano, Gustavo
[J]. SENSORS, 2024, 24 (02)

← 1 2 3 4 5 →